Annals of Gastroenterological Surgery最新文献

筛选
英文 中文
Textbook outcome contributes to long-term prognosis in elderly patients with esophageal squamous cell carcinoma 教科书结果有助于老年食管鳞状细胞癌患者的长期预后
IF 2.9 4区 医学
Annals of Gastroenterological Surgery Pub Date : 2024-03-26 DOI: 10.1002/ags3.12799
Chihiro Matsumoto, Masaaki Iwatsuki, Chishou Mitsuura, Atsushi Morito, Yuto Maeda, Tasuku Toihata, Keisuke Kosumi, Yoshifumi Baba, Naoya Yoshida, Hideo Baba
{"title":"Textbook outcome contributes to long-term prognosis in elderly patients with esophageal squamous cell carcinoma","authors":"Chihiro Matsumoto,&nbsp;Masaaki Iwatsuki,&nbsp;Chishou Mitsuura,&nbsp;Atsushi Morito,&nbsp;Yuto Maeda,&nbsp;Tasuku Toihata,&nbsp;Keisuke Kosumi,&nbsp;Yoshifumi Baba,&nbsp;Naoya Yoshida,&nbsp;Hideo Baba","doi":"10.1002/ags3.12799","DOIUrl":"10.1002/ags3.12799","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Purpose</h3>\u0000 \u0000 <p>Textbook outcome (TO) is a composite quality measurement of outcomes for evaluating surgical procedures. We investigated whether TO can be used to predict outcomes after curative resection for esophageal squamous cell carcinoma (ESCC) in elderly patients.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We retrospectively analyzed 105 patients who underwent curative esophagectomy for ESCC from 2005 to 2020. In accordance with previous reports, TO consisted of 10 parameters. The patients were divided into two groups: those who achieved TO (TO) and those who failed to achieve TO (non-TO). We evaluated the association between TO and long-term survival.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>TO was achieved in 28 (26%) patients. The patients in the TO group were significantly older (<i>p</i> = 0.02). The parameter with the lowest achievement rate was “No hospital stay ≥21 days”. The patients in non-TO group had significantly shorter overall survival than those in TO group (<i>p</i> = 0.03). Multivariable Cox regression analyses of overall survival revealed that lymph node metastasis (hazard ratio [HR], 3.42; 95% confidence interval [CI], 1.73–6.78; <i>p</i> &lt; 0.0002) and non-TO (HR, 2.37; 95% CI, 1.05–5.65; <i>p</i> = 0.03) were significantly associated with poor overall survival.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>TO can be used to predict outcomes after curative esophagectomy in elderly patients with ESCC.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":"8 5","pages":"787-794"},"PeriodicalIF":2.9,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.12799","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140380173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of the COVID-19 pandemic on short-term outcomes after pancreaticoduodenectomy for pancreatic cancer: A retrospective study from the Japanese National Clinical Database, 2018–2021 COVID-19大流行对胰腺癌胰十二指肠切除术后短期疗效的影响:2018-2021年日本国家临床数据库回顾性研究
IF 2.9 4区 医学
Annals of Gastroenterological Surgery Pub Date : 2024-03-23 DOI: 10.1002/ags3.12798
Yusuke Takemura, Hideki Endo, Taizo Hibi, Yutaka Nakano, Ryo Seishima, Masashi Takeuchi, Hiroyuki Yamamoto, Hiromichi Maeda, Kazuhiro Hanazaki, Akinobu Taketomi, Yoshihiro Kakeji, Yasuyuki Seto, Hideki Ueno, Masaki Mori, Yuko Kitagawa
{"title":"Impact of the COVID-19 pandemic on short-term outcomes after pancreaticoduodenectomy for pancreatic cancer: A retrospective study from the Japanese National Clinical Database, 2018–2021","authors":"Yusuke Takemura,&nbsp;Hideki Endo,&nbsp;Taizo Hibi,&nbsp;Yutaka Nakano,&nbsp;Ryo Seishima,&nbsp;Masashi Takeuchi,&nbsp;Hiroyuki Yamamoto,&nbsp;Hiromichi Maeda,&nbsp;Kazuhiro Hanazaki,&nbsp;Akinobu Taketomi,&nbsp;Yoshihiro Kakeji,&nbsp;Yasuyuki Seto,&nbsp;Hideki Ueno,&nbsp;Masaki Mori,&nbsp;Yuko Kitagawa","doi":"10.1002/ags3.12798","DOIUrl":"10.1002/ags3.12798","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>The coronavirus disease 2019 (COVID-19) pandemic greatly impacted medical resources such as cancer screening, diagnosis, and treatment given to people for various diseases. We surveyed the impacts of the pandemic on the incidence of complications and mortality following pancreaticoduodenectomy for pancreatic cancer in Japan.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Data on patients who underwent pancreaticoduodenectomy for pancreatic cancer were extracted from the Japanese National Clinical Database (NCD) between 2018 and 2021. The number of the pancreaticoduodenectomy for pancreatic cancer were obtained and then the morbidity and mortality rates were evaluated using a standardized morbidity/mortality ratio (SMR), which is the ratio of the observed number of incidences to the expected number of incidences calculated by the risk calculator previously developed by the NCD.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>This study included 22 255 cases. The number of pancreaticoduodenectomies exhibited an increasing trend even during the COVID-19 pandemic. The mean observed incidence rates of Grade C pancreatic fistula and Clavien–Dindo grade ≥4 complications, and the 30-day mortality and surgical mortality rates were 0.8%, 1.8%, 0.8% and 0.9%, respectively. The standardized morbidity ratios did not increase during the COVID-19 pandemic. The standardized mortality ratios remained within the range of variations observed before the COVID-19 pandemic.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The increasing trend in the number of pancreaticoduodenectomies and favorable short-term outcomes even in the COVID-19 pandemic suggest the medical care for pancreatic cancer in Japan functioned well during the pandemic.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":"8 5","pages":"877-887"},"PeriodicalIF":2.9,"publicationDate":"2024-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.12798","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140211150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overexpression of circular RNA hsa_circ_0008621 facilitates colorectal cancer progression and predicts poor prognosis 环状 RNA hsa_circ_0008621 的过表达可促进结直肠癌的进展并预测不良预后
IF 2.9 4区 医学
Annals of Gastroenterological Surgery Pub Date : 2024-03-22 DOI: 10.1002/ags3.12793
Xiaohu Zhou, Lei Wu, Chunyan Tian
{"title":"Overexpression of circular RNA hsa_circ_0008621 facilitates colorectal cancer progression and predicts poor prognosis","authors":"Xiaohu Zhou,&nbsp;Lei Wu,&nbsp;Chunyan Tian","doi":"10.1002/ags3.12793","DOIUrl":"10.1002/ags3.12793","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>To evaluate the potential role of serum and tissue hsa_circ_0008621 as a prognostic biomarker for CRC patients. Focused on the functional role of hsa_circ_0008621 in colorectal cancer (CRC).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Serum and tissue hsa_circ_0008621 expression were quantified by qRT-PCR in 157 CRC patients, as well as 100 serums from healthy controls. Serum and tissue hsa_circ_0008621 expression was evaluated for their prognostic role in CRC patients using Kaplan–Meier curves and Multivariate Cox proportional hazards analysis. To further characterize the biological role of hsa_circ_0008621 expression in CRC, in vitro hsa_circ_0008621 inhibition was performed and the effects on cellular growth, migration, invasion, apoptosis, and glycolysis were explored. Next, the downstream molecules for hsa_circ_0008621 were predicted.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Hsa_circ_0008621 expression was significantly upregulated in CRC tissues and serums. Serum hsa_circ_0008621 levels were significantly up-regulated in advanced-staged samples. High serum hsa_circ_0008621 expression was associated with shorter overall survival and recurrence-free survival in CRC patients. Multivariate Cox regression analysis identified a high level of serum hsa_circ_0008621 expression as an independent prognostic factor with respect to overall survival and recurrence-free survival. Loss of function assays for hsa_circ_0008621 in vitro led to a significant decrease in cell proliferation, migration, invasion, and glycolysis, but an increase in cell apoptosis. Hsa_circ_0008621 can sponge miR-532-5p, which targets SLC16A3.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>High level of serum hsa_circ_0008621 is associated with poor survival in CRC and promotes CRC progression, suggesting it to be a promising non-invasive prognostic biomarker and novel therapeutic target in CRC patients.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":"8 4","pages":"639-649"},"PeriodicalIF":2.9,"publicationDate":"2024-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.12793","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140212290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What defines the “value” of robotic surgery for patients with gastrointestinal cancers? Perspectives from a U.S. Cancer Center 什么定义了胃肠道癌症患者机器人手术的 "价值"?来自美国癌症中心的观点
IF 2.9 4区 医学
Annals of Gastroenterological Surgery Pub Date : 2024-03-21 DOI: 10.1002/ags3.12792
Naruhiko Ikoma
{"title":"What defines the “value” of robotic surgery for patients with gastrointestinal cancers? Perspectives from a U.S. Cancer Center","authors":"Naruhiko Ikoma","doi":"10.1002/ags3.12792","DOIUrl":"10.1002/ags3.12792","url":null,"abstract":"<p>The use of robotic surgery has experienced rapid growth across diverse medical conditions, with a notable emphasis on gastrointestinal cancers. The advanced technologies incorporated into robotic surgery platforms have played a pivotal role in enabling the safe performance of complex procedures, including gastrectomy and pancreatectomy, through a minimally invasive approach. However, there exists a noteworthy gap in high-level evidence demonstrating that robotic surgery for gastric and pancreatic cancers has substantial benefits compared to traditional open or laparoscopic methods. The primary impediment hindering the broader implementation of robotic surgery is its cost. The escalating healthcare expenses in the United States have prompted healthcare providers and payors to explore patient-centered, value-based healthcare models and reimbursement systems that embrace cost-effectiveness. Thus, it is important to determine what defines the value of robotic surgery. It must either maintain or enhance oncological quality and improve complication rates compared to open procedures. Moreover, its true value should be apparent in patients' expedited recovery and improved quality of life. Another essential aspect of robotic surgery's value lies in minimizing or even eliminating opioid use, even after major operations, offering considerable benefits to the broader public health landscape. A quicker return to oncological therapy has the potential to improve overall oncological outcomes, while a speedier return to work not only alleviates individual financial distress but also positively impacts societal productivity. In this article, we comprehensively review and summarize the current landscape of health economics and value-based care, with a focus on robotic surgery for gastrointestinal cancers.</p>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":"8 4","pages":"566-579"},"PeriodicalIF":2.9,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.12792","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140222815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative serum cholinesterase as a prognostic factor in patients with colorectal cancer 作为结直肠癌患者预后因素的术前血清胆碱酯酶
IF 2.9 4区 医学
Annals of Gastroenterological Surgery Pub Date : 2024-03-18 DOI: 10.1002/ags3.12794
Kimihiko Nakamura, Ryo Seishima, Shimpei Matsui, Kohei Shigeta, Koji Okabayashi, Yuko Kitagawa
{"title":"Preoperative serum cholinesterase as a prognostic factor in patients with colorectal cancer","authors":"Kimihiko Nakamura,&nbsp;Ryo Seishima,&nbsp;Shimpei Matsui,&nbsp;Kohei Shigeta,&nbsp;Koji Okabayashi,&nbsp;Yuko Kitagawa","doi":"10.1002/ags3.12794","DOIUrl":"10.1002/ags3.12794","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>Serum cholinesterase (ChE) levels are considered to reflect nutritional status. Although ChE has been well documented as a prognostic factor for some cancers, no clear consensus on its use for colorectal cancer (CRC) has been reached. The aim of this study was to investigate the relationship between preoperative serum ChE and postoperative long-term prognosis in CRC patients.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A total of 1053 CRC patients who underwent curative surgery were included in this study. The correlations between the preoperative ChE value and overall survival (OS) or cancer-specific survival (CSS) were assessed. By dividing patients into two groups according to their ChE value, OS and CSS were compared between the groups.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Multivariate analysis revealed that the continuous ChE value was a significant predictor of OS (hazard ratio, 0.996; 95% CI, 0.993–0.998; <i>p</i> = 0.002) and CSS (hazard ratio, 0.994; 95% CI, 0.991–0.998; <i>p</i> = 0.001), independent of other variables. The low-ChE (≤234 U/L) group had a significantly poorer prognosis than the high-ChE (&gt;234 U/L) group for both OS (5-year OS for low ChE and high ChE: 79.8% and 93.3%, respectively; <i>p</i> &lt; 0.001) and CSS (5-year CSS for low ChE and high ChE: 84.8% and 95.6%, respectively; <i>p</i> &lt; 0.001).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Lower preoperative serum ChE levels are a predictive factor of poor prognosis for CRC patients. As serum ChE levels can be measured quickly and evaluated easily, ChE could become a useful marker for predicting the postoperative long-term outcomes of CRC patients.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":"8 4","pages":"650-659"},"PeriodicalIF":2.9,"publicationDate":"2024-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.12794","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140234159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is multidisciplinary treatment effective for invasive intraductal papillary mucinous carcinoma? 多学科治疗对浸润性导管内乳头状黏液癌有效吗?
IF 2.9 4区 医学
Annals of Gastroenterological Surgery Pub Date : 2024-03-17 DOI: 10.1002/ags3.12790
Seiko Hirono, Ryota Higuchi, Goro Honda, Satoshi Nara, Minoru Esaki, Naoto Gotohda, Hideki Takami, Michiaki Unno, Teiichi Sugiura, Masayuki Ohtsuka, Yasuhiro Shimizu, Ippei Matsumoto, Toshifumi Kin, Hiroyuki Isayama, Daisuke Hashimoto, Yasuji Seyama, Hiroaki Nagano, Kenichi Hakamada, Satoshi Hirano, Yuichi Nagakawa, Shugo Mizuno, Hidenori Takahashi, Kazuto Shibuya, Hideki Sasanuma, Taku Aoki, Yuichiro Kohara, Toshiki Rikiyama, Masafumi Nakamura, Itaru Endo, Yoshihiro Sakamoto, Akihiko Horiguchi, Takashi Hatori, Hirofumi Akita, Toshiharu Ueki, Tetsuya Idichi, Keiji Hanada, Shuji Suzuki, Keiichi Okano, Hiromitsu Maehira, Fuyuhiko Motoi, Yasuhiro Fujino, Satoshi Tanno, Akio Yanagisawa, Yoshifumi Takeyama, Kazuichi Okazaki, Sohei Satoi, Hiroki Yamaue
{"title":"Is multidisciplinary treatment effective for invasive intraductal papillary mucinous carcinoma?","authors":"Seiko Hirono,&nbsp;Ryota Higuchi,&nbsp;Goro Honda,&nbsp;Satoshi Nara,&nbsp;Minoru Esaki,&nbsp;Naoto Gotohda,&nbsp;Hideki Takami,&nbsp;Michiaki Unno,&nbsp;Teiichi Sugiura,&nbsp;Masayuki Ohtsuka,&nbsp;Yasuhiro Shimizu,&nbsp;Ippei Matsumoto,&nbsp;Toshifumi Kin,&nbsp;Hiroyuki Isayama,&nbsp;Daisuke Hashimoto,&nbsp;Yasuji Seyama,&nbsp;Hiroaki Nagano,&nbsp;Kenichi Hakamada,&nbsp;Satoshi Hirano,&nbsp;Yuichi Nagakawa,&nbsp;Shugo Mizuno,&nbsp;Hidenori Takahashi,&nbsp;Kazuto Shibuya,&nbsp;Hideki Sasanuma,&nbsp;Taku Aoki,&nbsp;Yuichiro Kohara,&nbsp;Toshiki Rikiyama,&nbsp;Masafumi Nakamura,&nbsp;Itaru Endo,&nbsp;Yoshihiro Sakamoto,&nbsp;Akihiko Horiguchi,&nbsp;Takashi Hatori,&nbsp;Hirofumi Akita,&nbsp;Toshiharu Ueki,&nbsp;Tetsuya Idichi,&nbsp;Keiji Hanada,&nbsp;Shuji Suzuki,&nbsp;Keiichi Okano,&nbsp;Hiromitsu Maehira,&nbsp;Fuyuhiko Motoi,&nbsp;Yasuhiro Fujino,&nbsp;Satoshi Tanno,&nbsp;Akio Yanagisawa,&nbsp;Yoshifumi Takeyama,&nbsp;Kazuichi Okazaki,&nbsp;Sohei Satoi,&nbsp;Hiroki Yamaue","doi":"10.1002/ags3.12790","DOIUrl":"10.1002/ags3.12790","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Surgical resection is standard treatment for invasive intraductal papillary mucinous carcinoma (IPMC); however, impact of multidisciplinary treatment on survival including postoperative adjuvant therapy (AT), neoadjuvant therapy (NAT), and treatment for recurrent lesions is unclear. We investigated the effectiveness of multidisciplinary treatment in prolonging survival of patients with invasive IPMC.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This retrospective multi-institutional study included 1183 patients with invasive IPMC undergoing surgery at 40 academic institutions. We analyzed the effects of AT, NAT, and treatment for recurrence on survival of patients with invasive IPMC.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Completion of the planned postoperative AT for 6 months improved the overall survival (OS), disease-specific survival (DSS), and recurrence-free survival (RFS) of patients with stage IIB and stage III resected invasive IPMC, elevated preoperative carbohydrate antigen 19–9 level, lymphovascular invasion, perineural invasion, serosal invasion, and lymph node metastasis on un-matched and matched analyses. Of the patients with borderline resectable (BR) invasive IPMC, the OS (<i>p</i> = 0.001), DSS (<i>p</i> = 0.001), and RFS (<i>p</i> = 0.001) of patients undergoing NAT was longer than that of those without on the matched analysis. Of the 484 invasive IPMC patients (40.9%) who developed recurrence after surgery, the OS of 365 patients who received any treatment for recurrence was longer than that of those without treatment (40.6 vs. 22.4 months, <i>p</i> &lt; 0.001).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Postoperative AT might benefit selected patients with invasive IPMC, especially those at high risk of poor survival. NAT might improve the survivability of BR invasive IPMC. Any treatment for recurrence after surgery for invasive IPMC might improve survival.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":"8 5","pages":"845-859"},"PeriodicalIF":2.9,"publicationDate":"2024-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.12790","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140235208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of malnutrition and nutritional support after gastrectomy in patients with gastric cancer 胃癌患者胃切除术后营养不良和营养支持的影响
IF 2.9 4区 医学
Annals of Gastroenterological Surgery Pub Date : 2024-03-16 DOI: 10.1002/ags3.12788
Min Kyu Kang, Hyuk-Joon Lee
{"title":"Impact of malnutrition and nutritional support after gastrectomy in patients with gastric cancer","authors":"Min Kyu Kang,&nbsp;Hyuk-Joon Lee","doi":"10.1002/ags3.12788","DOIUrl":"10.1002/ags3.12788","url":null,"abstract":"<p>Malnutrition, characterized by altered body composition and impaired function, is particularly prevalent among gastric cancer patients, affecting up to 60% of them. Malnutrition in these patients can manifest both before and after surgery, due to factors such as gastric outlet obstruction, cancer cachexia, and anatomical changes. Notably, total gastrectomy (TG) presents the most significant nutritional challenges. However, function-preserving gastrectomy, such as pylorus-preserving gastrectomy (PPG) and proximal gastrectomy (PG), have shown promise in improving nutritional outcomes. Effective nutritional risk screening and assessment are vital for identifying patients at risk. Nutritional support not only improves nutritional parameters but also reduces complications, enhances quality of life (QoL) and survival rates. Those unable to maintain more than 50% of the recommended intake for over 7 days are recommended for nutritional support. Common methods of nutritional support include oral nutrition supplements (ONS), enteral nutrition (EN), or parenteral nutrition (PN) depending on the patient's status. Effect of perioperative nutritional support remains controversial. Preoperative interventions including ONS and PN have shown mixed results, with selective benefits in patients with sarcopenia or hypoalbuminaemia, while impact of EN in gastric outlet obstruction patients have been positive. In contrast postoperative support appears to be consistent. Tube feeding after TG has shown improvements, and ONS have been effective in reducing weight loss and improving nutritional biomarkers. PN was also associated with benefits such as weight maintenance and QoL. This review explores the mechanisms, assessment, and clinical impact of malnutrition, emphasizing the importance of nutritional support in gastric cancer patients undergoing gastrectomy.</p>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":"8 4","pages":"534-552"},"PeriodicalIF":2.9,"publicationDate":"2024-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.12788","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140236022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of laparoscopic and endoscopic cooperative surgery for gastric submucosal tumors: A retrospective multicenter study at 21 Japanese institutions 胃粘膜下肿瘤腹腔镜和内镜合作手术的疗效:日本 21 家医疗机构的多中心回顾性研究。
IF 2.9 4区 医学
Annals of Gastroenterological Surgery Pub Date : 2024-03-13 DOI: 10.1002/ags3.12787
Yoshikazu Hashimoto, Nobutsugu Abe, Souya Nunobe, Hirofumi Kawakubo, Tetsuya Sumiyoshi, Naohiro Yoshida, Yoshinori Morita, Masanori Terashima, Zenichiro Saze, Manabu Onimaru, Eigo Otsuji, Shu Hoteya, Haruhiro Yamashita, Takashi Fujimura, Tsuneo Oyama, Ken Ohata, Satoki Shichijo, Kazuaki Tanabe, Kiyohiko Shuto, Takashi Ikeya, Hisashi Shinohara, Satoshi Tanabe, Naoki Hiki
{"title":"Outcomes of laparoscopic and endoscopic cooperative surgery for gastric submucosal tumors: A retrospective multicenter study at 21 Japanese institutions","authors":"Yoshikazu Hashimoto,&nbsp;Nobutsugu Abe,&nbsp;Souya Nunobe,&nbsp;Hirofumi Kawakubo,&nbsp;Tetsuya Sumiyoshi,&nbsp;Naohiro Yoshida,&nbsp;Yoshinori Morita,&nbsp;Masanori Terashima,&nbsp;Zenichiro Saze,&nbsp;Manabu Onimaru,&nbsp;Eigo Otsuji,&nbsp;Shu Hoteya,&nbsp;Haruhiro Yamashita,&nbsp;Takashi Fujimura,&nbsp;Tsuneo Oyama,&nbsp;Ken Ohata,&nbsp;Satoki Shichijo,&nbsp;Kazuaki Tanabe,&nbsp;Kiyohiko Shuto,&nbsp;Takashi Ikeya,&nbsp;Hisashi Shinohara,&nbsp;Satoshi Tanabe,&nbsp;Naoki Hiki","doi":"10.1002/ags3.12787","DOIUrl":"10.1002/ags3.12787","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>We conducted a multicenter study on classical laparoscopic and endoscopic cooperative surgery (LECS) and LECS-related procedures to retrospectively clarify the safety, problems, and mid-term outcomes of these methods after their coverage by the national health insurance.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A total of 201 patients who underwent classical LECS/LECS-related procedures for gastric submucosal tumors (G-SMTs) in 21 institutions affiliated with the Laparoscopy Endoscopy Cooperative Surgery Study Group from April 2014 to March 2016 were included. Data was retrospectively obtained from the patients' charts.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The most common surgical procedure was classical LECS (155 patients, 77.1%), non-exposed endoscopic wall inversion surgery (22 patients, 11.4%), a combination of laparoscopic and endoscopic approaches to neoplasia with non-exposure technique (16 patients, 8%), and closed LECS (two patients, 1%). Only six (3%) patients underwent LECS with gastrostomy. The mean operative time and blood loss were 188.4 (70–462) minutes and 23.3 (0–793) g, respectively. Ten (5%) patients developed postoperative complications (Clavien–Dindo classification grade II or higher). Two patients needed reoperation due to postoperative bleeding or anastomotic leakage. All tumors were resected with negative margins. A total of 127 (63.2%) patients underwent follow-up observations for over 36 months, one of whom had a recurrence of peritoneal dissemination and one had poor oral intake.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Classical LECS and LECS-related procedures for G-SMTs have favorable short/mid-term outcomes.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":"8 5","pages":"778-786"},"PeriodicalIF":2.9,"publicationDate":"2024-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11368495/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142124627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to “A multicenter prospective observational study of lymph node metastasis patterns and short-term outcomes of extended lymphadenectomy in right-sided colon cancer” 更正 "关于右侧结肠癌淋巴结转移模式和扩大淋巴结切除术短期疗效的多中心前瞻性观察研究"。
IF 2.9 4区 医学
Annals of Gastroenterological Surgery Pub Date : 2024-03-13 DOI: 10.1002/ags3.12797
{"title":"Correction to “A multicenter prospective observational study of lymph node metastasis patterns and short-term outcomes of extended lymphadenectomy in right-sided colon cancer”","authors":"","doi":"10.1002/ags3.12797","DOIUrl":"10.1002/ags3.12797","url":null,"abstract":"<p>Tsukamoto S, Ouchi A, Komori K, Shiozawa M, Yasui M, Ohue M, et al. A multicenter prospective observational study of lymph node metastasis patterns and short-term outcomes of extended lymphadenectomy in right-sided colon cancer. <i>Ann Gastroenterol Surg</i>. 2023; 7: 940–948. https://doi.org/10.1002/ags3.12703</p><p>Subsequent to the issue publication, the authors added a supporting information file to the above article. This will help the readers understand the percentages shown in Figure 2.</p><p>The addition of the Supporting Information does not affect the above article.</p>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":"8 4","pages":"728"},"PeriodicalIF":2.9,"publicationDate":"2024-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11216778/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141490584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of lateral lymph node dissection for local control of rectal cancer: A multicenter study 侧淋巴结清扫术对局部控制直肠癌的疗效:一项多中心研究
IF 2.9 4区 医学
Annals of Gastroenterological Surgery Pub Date : 2024-03-12 DOI: 10.1002/ags3.12789
Yusuke Tanaka, Hitoshi Hino, Akio Shiomi, Kay Uehara, Jun Watanabe, Takeshi Nishikawa, Hideki Ueno, Yusuke Kinugasa, Kazushige Kawai, Yoichi Ajioka
{"title":"Efficacy of lateral lymph node dissection for local control of rectal cancer: A multicenter study","authors":"Yusuke Tanaka,&nbsp;Hitoshi Hino,&nbsp;Akio Shiomi,&nbsp;Kay Uehara,&nbsp;Jun Watanabe,&nbsp;Takeshi Nishikawa,&nbsp;Hideki Ueno,&nbsp;Yusuke Kinugasa,&nbsp;Kazushige Kawai,&nbsp;Yoichi Ajioka","doi":"10.1002/ags3.12789","DOIUrl":"10.1002/ags3.12789","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>This study aimed to evaluate the efficacy of lateral lymph node dissection (LLND) for rectal cancer by comparing the local control in patients with and without pathological lateral lymph node metastasis (LLNM).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We included 189 patients with rectal cancer who underwent total mesorectal excision and LLND at 13 institutions between 2017 and 2019. Patients with and without pathological LLNM were defined as the pLLNM (+) and (−) groups, respectively. Propensity score-matching helped to balance the basic characteristics of both groups. The incidences of local recurrence (LR) and lateral lymph node recurrence (LLNR) were compared between the groups.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>In the entire cohort, 39 of the 189 patients had pathological LLNM. The 3-year LR and LLNR rates were 18.3% and 4.0% (<i>p</i> = 0.01) and 7.7% and 3.3% (<i>p</i> = 0.22) in the pLLNM (+) and (−) groups, respectively. After propensity score matching, the data from 62 patients were analyzed. No significant differences in LR or LLNR were observed between both groups. The 3-year LR and LLNR rates were 16.4% and 9.8% (<i>p</i> = 0.46) and 9.7% and 9.8% (<i>p</i> = 0.99) in the pLLNM (+) and (−) groups, respectively.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>LLND would lead to comparable local control in the pLLNM (+) and (−) groups if the clinicopathological characteristics except for LLNM are similar.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8030,"journal":{"name":"Annals of Gastroenterological Surgery","volume":"8 4","pages":"631-638"},"PeriodicalIF":2.9,"publicationDate":"2024-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ags3.12789","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140249302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信